2021 Global Drugs of Abuse Testing Market for 12 Assays: Supplier Shares, Volume and Sales Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers
This new 318-page report from LeadingMarketResearch.com contains 68 tables and provides analysis of the global drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.
Contains 318 pages and 68 tables
The report provides test volume and sales forecasts by country and market segment for the following assays: Amphetamines, Antidepressants, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxphene.
During the next decade, the abused drug testing market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
This report is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual assay.
Contains 318 pages and 68 tables
More Publications
2019 Competing in the Global Point-of-Care Diagnostic Testing Market
US$ 25,500.00
March 2019
1230 pages
2017-2021 Vibrio Diagnostic Testing Market
US$ 3,915.00
February 2017
200 pages
2016-2020 World Mycoplasma Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs-Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts
US$ 3,480.00
March 2016
202 pages
2021 CEA Test Volume and Sales Forecasts: US, Europe, Japan-Hospitals, Commercial Labs, POC Locations
US$ 1,450.00
July 2021
-
2016-2020 Emerging Opportunities in the Campylobacter Diagnostic Testing Market
US$ 3,480.00
March 2016
230 pages
